Evaluation of cardiovascular risk factors in women with uterine leimyoma: Is there a link with atherosclerosis?

Balkan Medical Journal

Volumn 29, Issue 3, 2012, Pages 320-323

  Sivri, Nasir ^a   Yalta, Tülin ^b   Sayin, Cenk ^b   Yalta, Kenan ^a   Özpuyan, Fulya ^b   Taştekin, Ebru ^b   Yetkin, Ertan ^c  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b TRAKYA UNIVERSITY   (Turkey)

^c Ozel IMC Hastanesi   (Turkey)

Author keywords

Atherosclerosis; Cardiovascular risk factors; Diabetes mellitus; Hypertension; Smoking; Uterine leimyomata (UL)

Indexed keywords

ADULT; AGE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEX; SMOKING; UTERUS MYOMA;

EID: 84866699579     PISSN: 21463123     EISSN: 21463131     Source Type: Journal    
DOI: 10.5152/balkanmedj.2012.002     Document Type: Article

References (44)

1. Ross RK, Pike MC, Vessey MP, Bull D, Yeates D, Casagrande JT. Risk factors for uterine fibroids: reduced risk associated with oral contraceptives. Br Med J 1986;293:359-62. [CrossRef]
2. Vollenhoven B. Introduction: the epidemiology of uterine leiomyomas. Baillieres Clin Obstet Gynaecol 1998;12:169-76. [CrossRef]
3. Newbold RR, DiAugustine RP, Risinger JI, Everitt JI, Walmer DK, Parrott EC, et al. Advances in uterine leiomyoma research: conference overview, summary, and future research recommendations. Environ Health Perspect 2000;108:769-73. [CrossRef]
4. Cramer SF, Horiszny JA, Leppert P. Epidemiology of uterine leiomyomas. With an etiologic hypothesis. J Reprod Med 1995;40:595-600.
5. Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 2000;108:821-7. [CrossRef]
6. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7. [CrossRef]
7. Borgfeldt C, Andolf E. Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand 2000;79:202-7. [CrossRef]
8. Luoto R, Kaprio J, Rutanen EM, Taipale P, Perola M, Koskenvuo M. Heritability and risk factors of uterine fibroids-the Finnish Twin Cohort Study. Maturitas 2000;37:15-26. [CrossRef]
9. Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 990;94:435-8.
10. Marshall LM, Spiegelman D, Manson JE, Goldman MB, Barbieri RL, Stampfer MJ, et al. Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking. Epidemiology 1998;9:511-7. [CrossRef]
11. Boynton-Jarrett R, Rich-Edwards J, Malspeis S, A. Missmer S, Wright R. A prospective study of hypertension and risk of uterine leiomyomata. Am J Epidemiol 2005;161:628-38. [CrossRef]
12. Hashimoto K, Azuma C, Kamiura S, Kimura T, Nobunaga T, Kanai T, et al. Clonal determination of uterine leiomyomas by analyzing differential inactivation of the X-chromosome-linked phosphoglycerokinase gene. Gynecol Obstet Invest 1995;40:204-8. [CrossRef]
13. Wise LA, Palmer JR, Stewart EA, Rosenberg L. Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study. Obstet Gynaecol 2005;105:563-8. [CrossRef]
14. Kjerulff KH, Langenberg P, Seidman JD, Stolley PD, Guzinski GM. Uterine leiomyomas. Racial differences in severity, symptoms and age of diagnosis. J Reprod Med 1996;41:483-90.
15. Ligon AH, Morton CC. Leiomyomata: heritability and cytogenetic studies. Hum Reprod Update 2001;7:8-14. [CrossRef]
16. Chiaffarino F, Parazzini F, La Vecchia C, Marsico S, Surace M, Ricci E. Use of oral contraceptives and uterine fibroids: results from a casecontrol study. Br J Obstet Gynaecol 1999;106:857-60. [CrossRef]
17. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depotedroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre casecontrol study. Br J Obstet Gynaecol 1996;103:909-14. [CrossRef]
18. Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study I. African American heritage, reproductive history, body size, and smoking. Am J Epidemiol 2001;153:1-10. [CrossRef]
19. Okoronkwo MO. Body weight and uterine leiomyomas among women in Nigeria. West Afr J Med 1999;18:52-4.
20. Sato F, Nishi M, Kudo R, Miyake H. Body fat distribution and uterine leiomyomas. J Epidemiol 1998;8:176-80. [CrossRef]
21. Silver MA., Raghuvir R, Fedirko B, Esler D. Systemic hypertension among women with uterine leiomyomata: potential final common pathways of target end-organ remodeling. J Clin Hypertens (Greenwich) 2005;7:664-8. [CrossRef]
22. Kawano H, Do YS, Kawano Y, Starnes V, Barr M, Law RE, et al. Angiotensin II has multiple profibrotic effects in human cardiac fibroblast. Circulation 2000;101:1130-7. [CrossRef]
23. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest 1993;91:2268-74. [CrossRef]
24. Baker KM, Booz GW, Dostal DE. Cardiac actions of angiotensin II: role of intracardiac renin angiotensin system. Annu Rev Physiol 1992;54:227-41. [CrossRef]
25. Brandon DD, Bethea CL, Strawn EY, Novy MJ, Burry KA, Harrington MS, et al. Progesterone receptor messenger ribonucleic acid and protein are overexpressed in human uterine leiomyomas. Am J Obstet Gynecol 1993;169:78-85.
26. Dou Q, Zhao Y, Tarnuzzer RW, Rong H, Williams RS, Schultz GS, et al. Suppression of transforming growth factor-beta (TGF beta) and TGF beta receptor messenger ribonucleic acid and protein expression in leiomyomata in women receiving gonadotropinreleasing hormone agonist therapy. J Clin Endocrinol Metab 1996;81:3222-30. [CrossRef]
27. Wagenknecht LE, Zaccaro D, Espeland MA, Karter AJ, O'Leary DH, Haffner SM. Diabetes and progression of carotid atherosclerosis: the insulin resistance atherosclerosis study. Arterioscler Thromb Vasc Biol 2003;23:1035-41. [CrossRef]
28. Rajaram V, Pandhya S, Patel S, Meyer PM, Goldin M, Feinstein MJ, Neems R, Liebson PR, Fiedler BM, Macioch JE, Feinstein SB. Role of surrogate markers in assessing patients with diabetes mellitus and the metabolic syndrome and in evaluating lipid-lowering therapy. Am J Cardiol 2004;93(11A):32C-48C. [CrossRef]
29. Kornowski R, Mintz GS, Lansky J, Hong MK, Kent KM, Pichard AD, et al. Paradoxic decreases in atherosclerotic plaque mass in insulintreated diabetic patients. Am J Cardiol 1998;81:1298-304. [CrossRef]
30. Vavuranakis M, Stefanadis C, Toutouzas K, Pitsavos C, Spanos V, Toutouzas P. Impaired compensatory coronary artery enlargement in atherosclerosis contributes to the development of coronary artery stenosis in diabetic patients. An in vivo intravascular ultrasound study. Eur Heart J 1997;18:1090-4. [CrossRef]
31. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607. [CrossRef]
32. Yam D. Insulin-cancer relationships: possible dietary implication. Med Hypotheses 1992;38:111-7. [CrossRef]
33. Bornfeldt KE, Arnqvist HJ, Capron L. In vivo proliferation of rat vascular smooth muscle in relation to diabetes mellitus, insulinlike growth factor I and insulin. Diabetologia 1992;35:104-8. [CrossRef]
34. Cramer SF, Robertson AL Jr, Ziats NP, Pearson OH. Growth potential of human uterine leiomyomas: some in vitro observations and their implications. Obstet Gynecol 1985;66:36-41.
35. Poretsky L, Galin MF. The gonadotropic function of insulin. Endocr Rev 1987;8:132-41. [CrossRef]
36. Samadi AR, Lee NC, Flanders WD, Boring JR 3rd, Parris EB. Risk factors for selfreported uterine fibroids: a case-control study. Am J Public Health 1996;86:858-62. [CrossRef]
37. Parazzini F, Negri E, La Vecchia C, Rabaiotti M, Luchini L, Villa A, et al. Uterine myomas and smoking. Results from an Italian study. J Reprod Med 1996;41:316-20.
38. Baron JA, La Vecchia C, Levi F. The antiestrogenic effect of cigarette smoking in women. Am J Obstet Gynecol 1990;162:502-14.
39. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS:23). BMJ 1998;316:823-8. [CrossRef]
40. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR. UKPDS 59: Hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 2002;25:894-99. [CrossRef]
41. Li JM, Cui TX, Shiuchi T, Liu HW, Min LJ, Okumura M, et al. Nicotine enhances angiotensin II-induced mitogenic response in vascular smooth muscle cells and fibroblasts. Arterioscler Thromb Vasc Biol 2004;24:80-4. [CrossRef]
42. Mashal RD, Fejzo ML, Friedman AJ, Mitchner N, Nowak RA, Rein MS, et al. Analysis of androgen receptor DNA reveals the independent clonal origins of uterine leiomyomata and the secondary nature of cytogenetic aberrations in the development of leiomyomata. Genes Chromosomes Cancer 1994;11:1-6. [CrossRef]
43. Chung IM, Schwartz SM, Murry CE. Clonal architecture of normal and atherosclerotic aorta: implications for atherogenesis and vascular development. Am J Pathol 1998;152:913-23.
44. Moss NS, Benditt EP. Human atherosclerotic plaque cells and leiomyoma cells. Comparison of in vitro growth characteristics. Am J Pathol 1975;78:175-90.